InvestorsHub Logo
icon url

Rubberneck2

05/29/21 4:22 PM

#26574 RE: Cool888 #26573

After going on a year of holding I'm not going anywhere, but if I wasn't already deeply invested here I'd be looking elsewhere. That's no reflection on Revive Therapeutics, Michael Frank or Bucillamine, but I do have an ever growing and justified mistrust of government.
icon url

Classic Warrior

05/29/21 5:58 PM

#26575 RE: Cool888 #26573

I see that they got approval after 583 patients and state that " There are no adequate, approved and available alternative treatments to sotrovimab." However, Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research states “It is important to expand the arsenal of monoclonal antibody therapies that are expected to retain activity against the circulating variants of COVID-19 in the United States.”

Maybe they will throw us a bone to give doctors options. It's third down and 17. Should we hold the hail mary pass or wait until 4th down?

ps. Reluctantly, and slightly annoyed, we wait.
icon url

hotmeat

05/29/21 6:29 PM

#26576 RE: Cool888 #26573

Sotrovimab is an intramuscular shot so as things stand we are still in line to be the first pill treatment for Covid.